Gabriel S Morris insider trades

Open-market stock purchases and sales by Gabriel S Morris, CFO, President at Immix Biopharma, Inc, from SEC Form 4 filings since Dec 20, 2021.

Track record: 100% of 5 scored buys are up 5% or more since purchase, averaging +171%.

Recent trades

DateStockTradeValue
May 22, 2026IMMX Immix Biopharma, IncBought (not open market)—
Dec 10, 2025IMMX Immix Biopharma, IncBought$5.1K
Dec 8, 2025IMMX Immix Biopharma, IncBought (not open market)—
Dec 8, 2025IMMX Immix Biopharma, IncBought (not open market)$125K
Dec 8, 2025IMMX Immix Biopharma, IncBought (not open market)—

Companies traded

  • IMMX Immix Biopharma, Inc: 8 buys, last May 22, 2026

Get free alerts when Gabriel S Morris files a new trade →